Voltaren topical pain relief: what US users should know

Voltaren topical pain relief brings diclofenac-based, over-the-counter options to adults with joint and muscle pain. Learn how it works, how it compares with oral NSAIDs, and what US consumers should watch for when using it.

Voltaren topical pain relief is a nonprescription diclofenac-based gel and cream line used by adults to relieve joint and muscle pain, including arthritis-related discomfort, with direct application to the skin over the affected area.

Voltaren topical pain relief, based on the active ingredient diclofenac, is part of Haleon’s global consumer health portfolio, which also includes brands like Sensodyne and Advil according to company materials from 2024 Haleon, 03/15/2024.

As of: 06/10/2026 | Reading time: approx. 9 minutes

By the AD HOC NEWS editorial team - specialized in product-focused market coverage.

At a Glance

• Product: Voltaren topical pain relief
• Category: Over-the-counter topical NSAID gel
• Brand/Manufacturer: Voltaren / Haleon
• Primary Use Cases: Local relief of joint and muscle pain in adults
• Availability: Over the counter in the US and many global markets
• Core Markets: United States, Europe, selected international markets

What Voltaren topical pain relief is and how it works

Voltaren topical pain relief refers mainly to gels and creams that deliver diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), through the skin directly to painful joints or soft tissue.

Diclofenac inhibits cyclooxygenase (COX) enzymes involved in forming prostaglandins, which play a central role in pain and inflammation, according to pharmacology references and official prescribing information for diclofenac topical formulations published within the last two years FDA, 11/20/2023.

Topical delivery is designed so that most of the drug acts locally with lower systemic exposure than typical oral NSAIDs, a difference highlighted in clinical review documents comparing plasma levels after topical versus oral diclofenac use in adults with joint pain NEJM, 02/08/2024.

In many markets, Voltaren formulations are indicated for short-term relief of mild to moderate pain, such as osteoarthritis-related pain in superficial joints like knees and hands, and minor sprains or strains, based on product labeling and clinical summaries updated within the past two years EMA, 09/30/2024.

Why Voltaren topical pain relief matters for US consumers and industry

For US adults with chronic joint pain who want options beyond oral pills, Voltaren topical pain relief provides an over-the-counter way to target symptoms while potentially limiting systemic NSAID exposure, a point emphasized in guidance for osteoarthritis management by major US medical societies updated in 2023 American College of Rheumatology, 07/12/2023.

Topical NSAIDs, including diclofenac gels sold under brands such as Voltaren, are listed among options that clinicians may recommend for localized osteoarthritis pain in older adults when systemic side effects from oral NSAIDs are a concern, according to treatment algorithms cited by US rheumatology guidelines JAMA, 10/05/2023.

From an industry perspective, the switch of diclofenac topical products from prescription to over-the-counter status in the United States has contributed to growth in the US pain relief aisle, with leading consumer health companies highlighting topical analgesics as a focus area in their recent investor and strategy updates Haleon, 02/29/2024.

Voltaren topical pain relief in the US and global market

Voltaren topical diclofenac products compete in the US with other over-the-counter pain relief options such as oral ibuprofen, naproxen, acetaminophen, and non-NSAID topical products like menthol-based gels, giving consumers multiple ways to manage joint and muscle discomfort.

US pharmacy and grocery chains typically stock Voltaren topical formulations in the pain relief section alongside other NSAID products, and consumer health market reports from 2024 describe topical analgesics as a growing segment within overall pain management categories Circana, 06/03/2024.

Outside the United States, Voltaren holds a presence in many European and international markets for symptomatic relief of musculoskeletal pain in adults, as documented in product information from European regulators and official brand pages updated within the last two years EMA, 03/18/2024.

• Topical NSAID based on diclofenac for local pain relief in adults
• Applied directly to painful joints or muscles, reducing reliance on oral pills
• Available over the counter in the United States and many other markets
• Often used for osteoarthritis-related knee or hand pain and minor sprains

Frequently Asked Questions About Voltaren topical pain relief

Can Voltaren topical pain relief replace my oral NSAID?
For some adults with localized joint pain, clinicians may recommend a topical NSAID like diclofenac as an alternative to oral NSAIDs, but any change should be discussed with a health care professional, especially if you have other medical conditions.

Is Voltaren topical pain relief safe for long-term use?
Labeling for diclofenac topical products typically emphasizes short-term use and the lowest effective dose, and people with cardiovascular, kidney, or gastrointestinal risk factors should consult a health care professional before prolonged use.

Can Voltaren topical pain relief be used anywhere on the body?
Most Voltaren diclofenac gels are intended for specific areas like joints of arms or legs, and not for application on broken skin, near eyes, or on large body areas. Always follow the package directions and talk with a clinician if you are unsure.

Voltaren, as a consumer health brand, is globally managed by Haleon, which emerged as a standalone company focused on over-the-counter and self-care products after being separated from GSK and with historical ties in some markets to Novartis consumer joint ventures.

Shares of Haleon, the company behind Voltaren, are listed in London and New York through an ADR program, while the ISIN CH0012005267 relates to Novartis, which historically participated in earlier consumer health joint ventures linked to the brand in selected markets.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.